P Margolis, MD
Clinical Cardiac Electrophysiology · Wichita, KSNPI 1619921855
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,572 of the $6,501 with a category attached, or 85.7%. 13 manufacturers reported payments, led by Medtronic at 58.8% of the total. Reporting peaked in 2024 at $2,745 and has fallen 64.4% since, to $976 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in KS, where the typical reported total is $20,088.
Across 127 payments — averaging $51.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$1K
- Biosense Webster, Inc.$408
- Abbott$253
- Edwards Lifesciences$195
- Atricure, Inc.$166
- plus $314 from 7 others
Across 7 payments — averaging $680.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$5K
What the payments were for
- Travel & lodging$87814%
- Food & beverage$5,57286%
- Education$511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 75 | $3,824 |
| Boston Scientific | 33 | $1,341 |
| Biosense Webster, Inc. | 6 | $408 |
| Abbott | 3 | $253 |
| Edwards Lifesciences | 2 | $195 |
| Atricure, Inc. | 1 | $166 |
| Angiodynamics, Inc. | 1 | $115 |
| Preventice Services, LLC | 1 | $114 |
| Lantheus Medical Imaging, Inc. | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Pfizer | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVERA MRI XT DR SURESCAN$811
- Micra$556
- AURORA EV-ICD MRI SURESCAN$251
- Edwards SAPIEN 3 Transcatheter Heart Valve$166
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$166
- Xience V coronary stent system$144
- LOOP$125
- COBALT DR MRI SURESCAN$124
- GENERAL - THERAPIES$123
- Rhythmia Mapping System$118
- BG Mini Plus$114
- Carto 3$113
- SYMPLICITY G3$110
How this compares
$6,501 in reported general payments places this provider in the 15th percentile of 37 clinical cardiac electrophysiology providers in Kansas.
See all clinical cardiac electrophysiology providers in Kansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,081 | $1,052,088 |
| XareltoRivaroxaban | 235 | $282,142 |
| EntrestoSacubitril/Valsartan | 150 | $158,522 |
| JardianceEmpagliflozin | 31 | $35,693 |
| FarxigaDapagliflozin Propanediol | 34 | $25,612 |
| SotalolSotalol Hcl | 712 | $15,785 |
| Flecainide Acetate | 369 | $15,575 |
| Amiodarone Hcl | 508 | $7,640 |
| Metoprolol Succinate | 560 | $6,377 |
| Dofetilide | 28 | $4,809 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 224 | $4,336 |
| Diltiazem 24hr ErDiltiazem Hcl | 89 | $2,619 |
| Midodrine Hcl | 25 | $2,498 |
| Propafenone Hcl | 22 | $2,033 |
| Nebivolol Hcl | 20 | $1,435 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $1,052,0881,081 claims |
| NovartisEntresto | $14 | $158,522150 claims |
| AstraZenecaFarxiga | $14 | $25,61234 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 37 clinical cardiac electrophysiology providers in Kansas.
Other clinical cardiac electrophysiology in Wichita
- Olakanmi OlagokeWichita$42K
- Amit KoduriWichita$39K
- Ghiyath Al-TabbalWichita$22K
- Dhaval ParikhWichita$11K
- Christos MandanisWichita$10K
- Jesus Val MejiasWichita$2K
- Ashok BajajWichita$141
- Dhanunjaya LakkireddyKansas City$1.1M
- Rakesh GopinathannairOverland Park$425K
- Rhea PimentelKansas City$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.